SALT LAKE CITY (AP) — SALT LAKE CITY (AP) — Myriad Genetics Inc. (MYGN) on Tuesday reported a loss of $31.2 million in its fourth quarter.
The Salt Lake City-based company said it had a loss of 36 cents per share. Earnings, adjusted for non-recurring costs and stock option...
